|
|
11. The Critical Link
Between Hypertension and Diabetes: Evidence Based Medicine and Emerging Options Sunday,
September 17, 2000
14:30-17:00
| 14:00-14:30 |
Reception |
| 14:30-14:40 |
Introductory Remarks
Hans-Henrik Parving, Denmark, chairperson |
| 14:40-15:00 |
The Escalating Risk of Patients with Hypertension and
Diabetes
Steven M. Haffner, USA |
| 15:00-15:10 |
Q and A |
| 15:10-15:30 |
Hot Issues in High-Risk Hypertensive Patients with Diabetes:
Morbidity and Mortality Evidence for the Use of Antihypertensive Therapy
Mordchai Ravid, Israel |
| 15:30-15:40 |
Q and A |
| 15:40-16:00 |
Renal Pathology Patterns in Diabetes Mellitus
Edmund J. Lewis, USA |
| 16:00-16:10 |
Q and A |
| 16:10-16:30 |
Treating High-Risk Hypertensive Patients: The Programme for
Irbesartan
Mortality and Morbidity Evaluations (PRIME)
Julia Lewis, USA |
| 16:30-16:40 |
Q and A |
| 16:40-17:00 |
Panel Discussion
Hans-Henrik Parving, chairperson |
ICC - Jerusalem International Convention Center - Hall A
Hans-Henrik Parving, Denmark
Bristol-Myers Squibb/Sanofi-Synthelabo
 FOR
GENERAL ENQUIRIES
James O'Gara
Advantage Communications, LLC
132 West 36th Street, Fourth Floor
New York, New York, 10018, USA
Fax: +1 212 594 6150
E-mail: james.ogara@advantageus.com
|
